Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Empatica is an affective computing company focused on human data analytics.
Thermalin offers insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Kasha delivers pharmaceutical products and household goods to low-income consumers, resellers, pharmacies, and health facilities.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for severe immune-mediated inflammation.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
The AI Platform for Pharma Commercialization
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.
Portal Instruments is an early stage company that offers medical device.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Earendil Labs is a biotechnology company developing technology platforms that transform therapeutic protein discovery.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Sanofi has invested in 131 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Earendil Labs received $787.0M in a Venture - Series Unknown round. Sanofi's total known invested capital is $5.4B.
Sanofi's average investment size is $115.1M across its portfolio of 131 companies.
Recent Sanofi portfolio additions include ReCode Therapeutics, Korsana Biosciences, Empatica, Thermalin, MeiraGTx. These companies were founded in 2020 or later.